Recro to Report Financial Results for First Quarter 2021

Recro Pharma

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced that the company will release financial results for the first quarter of 2021 after the market close on Thursday, May 6, 2021. Recro’s management team will host a conference call and audio webcast at 4:30 p.m. ET on Thursday, May 6, 2021 to discuss the financial results and recent operational highlights.

To access the live conference call dial (844) 243-4691 from the U.S. or (225) 283-0379 from outside the U.S. at least ten minutes prior to the start time and reference conference ID 4898666. Those interested in listening to the conference call live via webcast may do so by visiting the “Events” page in the Investor section of the Company’s website, www.recrocdmo.com. In addition, an archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.

READ:  Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting

Recro (is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.